{
  "docId": "019de073-4386-7700-b700-92166fcbcd7c",
  "docSlug": "fd316ea801ff13186537922fd8d6b6b2",
  "documentTitle": "BioNTech | Investor Presentation Deck | 28 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 28,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide uses a list-based timeline/milestone format to highlight growth across five key areas.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-4386-7700-b700-92166fcbcd7c/9",
  "deckHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c",
  "deckJsonHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c.json",
  "deckAnchorHref": "/decks/019de073-4386-7700-b700-92166fcbcd7c#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.92,
        "x": 0.04,
        "y": 1
      },
      "kind": "list",
      "text": "Expansion of R&D and production teams: Increased R&D and production teams to >2,000 professionals",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "10d0ef48-ef3a-4303-b4b8-71888b5cfd20",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.92,
        "x": 0.04,
        "y": 1
      },
      "kind": "list",
      "text": "Expansion of oncology pipeline: Nine oncology clinical trials started; clinical results from six phase 1 studies",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "37dad303-b44f-46a7-bfbb-3688d97ad21f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.92,
        "x": 0.04,
        "y": 1
      },
      "kind": "list",
      "text": "Global presence: Established offices in Singapore, China and Turkey",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8142338d-bd1e-4d42-acdc-b1367d47444b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.92,
        "x": 0.04,
        "y": 1
      },
      "kind": "list",
      "text": "Production capacity: Expansion of commercial scale mRNA production and addition of US cell therapy manufacturing facility",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c59dbbd-a591-422e-ab5a-7141af6360ff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.92,
        "x": 0.04,
        "y": 1
      },
      "kind": "list",
      "text": "Commercial infrastructure: Deployed commercial team in Germany",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "da197342-07d7-4bee-89ec-f201cd20ffb1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.35,
        "x": 0.08,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1 As of December 31, 2021, BioNTech Group; R&D: Research & development",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d0be6bcf-a2a9-4b1b-936b-f025b670dce4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.45,
        "x": 0.04,
        "y": 0.09
      },
      "kind": "title",
      "text": "2021: A Year of Transformation & Progress",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0baee9fc-39ab-459f-a815-bd798f8d8d51",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "969ae496-b646-4eda-a7e1-1113896c949b",
      "evidence": "The slide uses a structured list of milestones to communicate progress.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 28,
      "from": 6,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "3cf6d9b3-9631-47e6-918d-3327cacea976",
      "evidence": "The presentation follows a 'why-what-how' structure",
      "position": 0,
      "objective": "Why BioNTech's approach is necessary and beneficial",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}